Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1980 Nov;42(5):635–644. doi: 10.1038/bjc.1980.296

Oestrogen receptors in breast tumours: associations with age, menopausal status and epidemiological and clinical features in 735 patients.

J M Elwood, W Godolphin
PMCID: PMC2010532  PMID: 7459204

Abstract

Comparisons between oestrogen-receptor (RE)-positive or negative patients were made on a continuous series of 735 patients with primary breast tumours seen at the major treatment centre in British Columbia between 1975 and 1978. RE positivity was commoner in older patients, and was not associated with menopausal status independently of age. The concentration of receptor protein also increased with increasing age, but was not affected by menopausal status. Neither RE status nor quantity was associated with any of the epidemiological risk factors studied, which included parity, age at first birth, weight, family history and exposure to oestrogenic drugs and oral contraceptives. Patients with RE- tumours were more likely to present with symptoms other than a breast lump, pain or nipple inversion, and had less-differentiated tumours; they did not differ from RE+ patients in terms of stage, size of tumour, or interval from first symptom. These findings are discussed in terms of the biological origin and determinants of oestrogen receptors.

Full text

PDF
635

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allegra J. C., Lippman M. E., Thompson E. B., Simon R. An association between steroid hormone receptors and response to cytotoxic chemotherapy in patients with metastatic breast cancer. Cancer Res. 1978 Nov;38(11 Pt 2):4299–4304. [PubMed] [Google Scholar]
  2. Allegra J. C., Lippman M. E., Thompson E. B., Simon R., Barlock A., Green L., Huff K. K., Do H. M., Aitken S. C. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer. Cancer Res. 1979 May;39(5):1447–1454. [PubMed] [Google Scholar]
  3. Bishop H. M., Blamey R. W., Elston C. W., Haybittle J. L., Nicholson R. I., Griffiths K. Relationship of oestrogen-receptor status to survival in breast cancer. Lancet. 1979 Aug 11;2(8137):283–284. doi: 10.1016/s0140-6736(79)90295-2. [DOI] [PubMed] [Google Scholar]
  4. Cooke T., George D., Shields R., Maynard P., Griffiths K. Oestrogen receptors and prognosis in early breast cancer. Lancet. 1979 May 12;1(8124):995–997. doi: 10.1016/s0140-6736(79)92752-1. [DOI] [PubMed] [Google Scholar]
  5. Fishman J., Nisselbaum J. S., Menendez-Botet C. J., Schwartz M. K. Estrone and estradiol content in human breast tumors: relationship to estradiol receptors. J Steroid Biochem. 1977 Aug;8(8):893–896. doi: 10.1016/0022-4731(77)90100-5. [DOI] [PubMed] [Google Scholar]
  6. Fujimoto I., Hanai A., Oshima A. Descriptive epidemiology of cancer in Japan: current cancer incidence and survival data. Natl Cancer Inst Monogr. 1979 Nov;(53):5–15. [PubMed] [Google Scholar]
  7. Garola R. E., McGuire W. L. An improved assay for nuclear estrogen receptor in experimental and human breast cancer. Cancer Res. 1977 Sep;37(9):3333–3337. [PubMed] [Google Scholar]
  8. Horwitz K. B., McGuire W. L. Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. J Biol Chem. 1978 Apr 10;253(7):2223–2228. [PubMed] [Google Scholar]
  9. Hähnel R., Twaddle E. Factors that may influence the estradiol receptor assay in human tissues:sex hormone binding globulin and endogenous steroids. J Steroid Biochem. 1979 Jan;10(1):95–98. doi: 10.1016/0022-4731(79)90147-x. [DOI] [PubMed] [Google Scholar]
  10. Kern W. H. Morphologic and clinical aspects of estrogen receptors in carcinoma of the breast. Surg Gynecol Obstet. 1979 Feb;148(2):240–242. [PubMed] [Google Scholar]
  11. Kiang D. T., Frenning D. H., Goldman A. I., Ascensao V. F., Kennedy B. J. Estrogen receptors and responses to chemotherapy and hormonal therapy in advanced breast cancer. N Engl J Med. 1978 Dec 14;299(24):1330–1334. doi: 10.1056/NEJM197812142992403. [DOI] [PubMed] [Google Scholar]
  12. Knight W. A., Livingston R. B., Gregory E. J., McGuire W. L. Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res. 1977 Dec;37(12):4669–4671. [PubMed] [Google Scholar]
  13. Lippman M. E., Allegra J. C., Thompson E. B., Simon R., Barlock A., Green L., Huff K. K., Do H. M., Aitken S. C., Warren R. The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer. N Engl J Med. 1978 Jun 1;298(22):1223–1228. doi: 10.1056/NEJM197806012982203. [DOI] [PubMed] [Google Scholar]
  14. MANTEL N., HAENSZEL W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959 Apr;22(4):719–748. [PubMed] [Google Scholar]
  15. Masters J. R., Hawkins R. A., Sangster K., Hawkins W., Smith I. I., Shivas A. A., Roberts M. M., Forrest A. P. Oestrogen receptors, cellularity, elastosis and menstrual status in human breast cancer. Eur J Cancer. 1978 Mar;14(3):303–307. doi: 10.1016/0014-2964(78)90194-9. [DOI] [PubMed] [Google Scholar]
  16. Maynard P. V., Blamey R. W., Elston C. W., Haybittle J. L., Griffiths K. Estrogen receptor assay in primary breast cancer and early recurrence of the disease. Cancer Res. 1978 Nov;38(11 Pt 2):4292–4295. [PubMed] [Google Scholar]
  17. McGuire W. L. Hormone receptors: their role in predicting prognosis and response to endocrine therapy. Semin Oncol. 1978 Dec;5(4):428–433. [PubMed] [Google Scholar]
  18. Meyer J. S., Bauer W. C., Rao B. R. Subpopulations of breast carcinoma defined by S-phase fraction, morphology, and estrogen receptor content. Lab Invest. 1978 Sep;39(3):225–235. [PubMed] [Google Scholar]
  19. Meyer J. S., Rao B. R., Stevens S. C., White W. L. Low incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replication. Cancer. 1977 Nov;40(5):2290–2298. doi: 10.1002/1097-0142(197711)40:5<2290::aid-cncr2820400541>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  20. Meyer J. S., Stevens S. C., Vandillen N., White W. L. Estrogen receptor assay of mammary carcinomas. Effects of testosterone-estradiol-binding globulin (TeBG) and serum estradiol-17 beta. Am J Clin Pathol. 1979 Oct;72(4):564–570. doi: 10.1093/ajcp/72.4.564. [DOI] [PubMed] [Google Scholar]
  21. Meyer J. S., Stevens S. C., White W. L., Hixon B. Estrogen receptor assay of carcinomas of the breast by a simplified dextran--charcoal method. Am J Clin Pathol. 1978 Oct;70(4):655–664. doi: 10.1093/ajcp/70.4.655. [DOI] [PubMed] [Google Scholar]
  22. Muschenheim F., Furst J. L., Bates H. A. Increased incidence of positive tests for estrogen binding in mammary carcinoma specimens transported in liquid nitrogen. Am J Clin Pathol. 1978 Nov;70(5):780–782. doi: 10.1093/ajcp/70.5.780. [DOI] [PubMed] [Google Scholar]
  23. Nomura Y., Kobayashi S., Takatani O., Sugano H., Matsumoto K., McGuire W. L. Estrogen receptor and endocrine responsiveness in Japanese versus American breast cancer patients. Cancer Res. 1977 Jan;37(1):106–110. [PubMed] [Google Scholar]
  24. Rosen P. P., Menendez-Botet C. J., Nisselbaum J. S., Urban J. A., Miké V., Fracchia A., Schwartz M. K. Pathological review of breast lesions analyzed for estrogen receptor protein. Cancer Res. 1975 Nov;35(11 Pt 1):3187–3194. [PubMed] [Google Scholar]
  25. Saez S., Martin P. M., Chouvet C. D. Estradiol and progesterone receptor levels in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels. Cancer Res. 1978 Oct;38(10):3468–3473. [PubMed] [Google Scholar]
  26. Sakai F., Saez S. Existence of receptors bound to endogenous estradiol in breast cancers of premenopausal and postmenopausal women. Steroids. 1976 Jan;27(1):99–110. doi: 10.1016/0039-128x(76)90071-4. [DOI] [PubMed] [Google Scholar]
  27. Silverstrini R., Daidone M. G., Di Fronzo G. Relationship between proliferative activity and estrogen receptors in breast cancer. Cancer. 1979 Aug;44(2):665–670. doi: 10.1002/1097-0142(197908)44:2<665::aid-cncr2820440237>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  28. Theve N. O., Carlström K., Gustafsson J. A., Gustafsson S., Nordenskjöld B., Sköldefors H., Wrange O. Oestrogen receptors and peripheral serum levels of oestradiol-17beta in patients with mammary carcinoma. Eur J Cancer. 1978 Dec;14(12):1337–1340. doi: 10.1016/0014-2964(78)90115-9. [DOI] [PubMed] [Google Scholar]
  29. Wagner R. K., Jungblut P. W. Oestradiol- and dihydrotestosterone receptors in normal and neoplastic human mammary tissue. Acta Endocrinol (Copenh) 1976 May;82(1):105–120. doi: 10.1530/acta.0.0820105. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES